Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

PBI, BJRI and AXTA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 7, 2025.

As a market capitalization-weighted index, the negative changes in the biggest stocks, did the most to drive the overall index lower. We think the S&P 500 still has potentially another 5-7% to fall.

WINTER HAVEN, Fla. , April 7, 2025 /PRNewswire/ -- SouthState announces a group of new hires and promotions in the Private Wealth, Small Business and Commercial Banking divisions.

Berkshire Hathaway (NYSE: BRK.A, BRK.B) has not been immune to the latest wave of stock market turbulence.

Last week's economic landscape was dramatically reshaped by President Trump's announcement of sweeping tariff policies on what he declared “Liberation Day.” His announcement triggered a historic sell-off in the stock market.

The gold market continues to see a lot of forced selling, as traders are trying to cover the overleveraged positions they chose to open in other markets. This being the case, gold will continue to be noisy, as traders have to take this into account, while recognizing that gold is

Just about three years have passed since Capital Group entered the ETF ecosystem. Responding to advisor demand, per head of ETFs Scott Davis, the firm added six core strategies in the ETF wrapper.

LOS ANGELES , April 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semtech Corporation ("Semtech" or "the Company") (NASDAQ: SMTC) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 27, 2024 and February 7, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 21, 2025.

Monday, April 7, 2025 Dear Shareholders and Investors, Non-Executive Vice Chairman of NAT, Alexander Hansson, has today bought 100,000 shares at $2.19 per share. He is now holding 4,400,000 shares.

HOLX's diagnostics strength, robust international potential and new board addition support its "Hold" case. Yet, ongoing global uncertainties remain a drag.

President Trump's tariffs have led to an $8 trillion market cap loss in the S&P 500, far outweighing the $1.2 trillion trade deficit. Higher tariffs act as a sales tax on consumers, increasing living costs, potentially causing inflation, and risking GDP growth and stock market stability.

LOS ANGELES , April 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Venture Global, Inc. ("Venture Global" or "the Company") (NYSE: VG) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents in connection with its initial public offering ("IPO") conducted on January 24, 2025, are encouraged to contact the firm before April 18, 2025.

Julianna Tatelbaum joins CNBC's 'Squawk on the Street' to discuss how foreign auto companies are reacting to tariff announcements from the U.S.

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of XP Inc. (“XP” or the “Company”) (NASDAQ: XP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

LOS ANGELES , April 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ: NTLA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 30, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

Shares of pharma giants like PFE, J&J, AZN, MRK and ABBV decline on investor concerns that retaliatory tariffs could drive up drug prices for U.S. consumers.

DLAKY, SAN and FET made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 7, 2025.

Globus Medical acquires Nevro Corp. to expand its presence in the $2.50 billion musculoskeletal market.

This as an opportune time to accumulate high-quality energy names such as PROP, HPK and FTK.